Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-29

Clinical Trial Update: Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting efficacy and safety of entecavir maleate tablets in Chinese patients with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entecavir maleate tablets (entecavir maleate)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED